Literature DB >> 11561579

Applications of acute phase reactants in infectious diseases.

H L Johnson1, C C Chiou, C T Cho.   

Abstract

The elevation of acute phase reactants (APRs) is a nonspecific host response to infection, inflammation, and tissue injury. The major biologic function of APRs is to restore homeostasis and to improve survival. Measuring the alterations in APRs can be a useful clinical marker when an infection or inflammatory response is suspected. Serum levels of reactants like fibrinogen and complement proteins increase as part of the inflammatory response, but the increase is trivial and does not contribute to the differential diagnosis or the evaluation of therapeutic responsiveness. By contrast, C-reactive protein (CRP) concentrations increase markedly with acute invasive infections which parallel the severity of inflammation or tissue injury. This advantage makes CRP a useful marker for the presence of disease, response to therapy, and ultimate recovery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11561579

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  22 in total

Review 1.  Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review.

Authors:  Victor van der Meer; Arie Knuistingh Neven; Peterhans J van den Broek; Willem J J Assendelft
Journal:  BMJ       Date:  2005-06-24

2.  Long-Term Outcomes and Predictors of Sustained Response in Patients with Intestinal Behcet's Disease Treated with Infliximab.

Authors:  Jun Zou; Da-Nian Ji; Jian-Fei Cai; Jian-Long Guan; Zhi-Jun Bao
Journal:  Dig Dis Sci       Date:  2017-01-02       Impact factor: 3.199

Review 3.  Acute phase response in animals: a review.

Authors:  Carolyn Cray; Julia Zaias; Norman H Altman
Journal:  Comp Med       Date:  2009-12       Impact factor: 0.982

4.  Microbial Translocation Associated with an Acute-Phase Response and Elevations in MMP-1, HO-1, and Proinflammatory Cytokines in Strongyloides stercoralis Infection.

Authors:  Anuradha Rajamanickam; Saravanan Munisankar; Yukthi Bhootra; Chandrakumar Dolla; Thomas B Nutman; Subash Babu
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

5.  Quantitation of acute phase proteins and protein electrophoresis in monitoring the acute inflammatory process in experimentally and naturally infected mice.

Authors:  Carolyn Cray; David G Besselsen; Jody L Hart; David Yoon; Marilyn Rodriguez; Julia Zaias; Norman H Altman
Journal:  Comp Med       Date:  2010-08       Impact factor: 0.982

Review 6.  Systematic review of the evidence of a relationship between chronic psychosocial stress and C-reactive protein.

Authors:  Timothy V Johnson; Ammara Abbasi; Viraj A Master
Journal:  Mol Diagn Ther       Date:  2013-06       Impact factor: 4.074

7.  Serological proteomics of gastritis: degradation of apolipoprotein A-I and alpha1-antitrypsin is a common response to inflammation irrespective of Helicobacter pylori infection.

Authors:  Qing-Yu He; Huaiyi Yang; Benjamin C Y Wong; Jen-Fu Chiu
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

8.  C-reactive protein levels during a relapse of Crohn's disease are associated with the clinical course of the disease.

Authors:  Chantal L Koelewijn; Matthijs P Schwartz; Melvin Samsom; Bas Oldenburg
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

9.  Cefditoren and ceftriaxone enhance complement-mediated immunity in the presence of specific antibodies against antibiotic-resistant pneumococcal strains.

Authors:  Elisa Ramos-Sevillano; Cinthya Rodríguez-Sosa; Fabio Cafini; Maria-Jose Giménez; Ana Navarro; David Sevillano; Luis Alou; Ernesto García; Lorenzo Aguilar; Jose Yuste
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

10.  Significant role of serum CRP in differentiating inflammatory from non-inflammatory causes of thyrotoxicosis.

Authors:  Manash P Baruah; Bhaskar Bhattacharya
Journal:  Indian J Endocrinol Metab       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.